ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

NCI, DCT Board Cool Toward AMA, ACOS, VA Role In Clinical Trials

March 3, 1989

In Surprising Result, Survey Of Centers Finds Little “Crisis” In Clinical Research

September 29, 1995

BSA Approves Concept For Ovarian Cancer SPORE Grant

June 26, 1998

In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13

April 10, 1981

Funding Mechanisms: How They Are Used

August 12, 1983

In Brief: ACCC Celebrates 25th: James Hospital Receives Large Donations

April 9, 1999